Monogram Orthopaedics Advances Towards FDA Clearance
Express News | Monogram Technologies Inc: Anticipates to Respond to FDA Air for Mbôs Tka System With Supplemental Data in Q1 2025
Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting With FDA
Roth MKM Initiates Monogram Orthopaedics(MGRM.US) With Buy Rating, Announces Target Price $4
Monogram Orthopaedics Price Target Announced at $4.00/Share by Roth MKM
Monogram Orthopaedics Initiated at Buy by Roth MKM
Roth MKM Initiates Coverage On Monogram Technologies With Buy Rating, Announces Price Target of $4
Monogram Technologies Analyst Ratings
"Buy Rating for Monogram Orthopaedics: Promising Robotics Platform and Strategic Market Positioning"
Monogram Orthopaedics Execs Invest Amid Strategic Expansion
Monogram Technologies Announces Management And Related Parties Complete Open Market Purchases Of MGRM Common Stock Totaling $1M
Monogram Technologies Inc. (MGRM) Q3 2024 Earnings Call Transcript
Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely?
Monogram Technologies Q3 EPS $(0.16) Down From $(0.03) YoY
Monogram Orthopaedics | 10-Q: Q3 2024 Earnings Report
Monogram Orthopaedics | 8-K: Monogram Technologies Reports Third Quarter 2024 Financial Results
Earnings Preview: MGRM to Report Financial Results Post-market on November 19
$Monogram Orthopaedics(MGRM.US)$ is scheduled to release its financial results post-market on November 19 ET. Earnings PreviewAnalysts estimate $Monogram Orthopaedics(MGRM.US)$ to post revenue of USD0
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 P.m. Eastern Time
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
No Data